|
HS Code |
593249 |
| Product Name | Benserazide Hydrochloride |
| Cas Number | 14919-77-8 |
| Molecular Formula | C10H15N3O5·HCl |
| Molecular Weight | 293.70 g/mol |
| Appearance | White to off-white powder |
| Solubility | Soluble in water |
| Storage Temperature | 2-8°C |
| Purity | ≥98% |
| Synonyms | Serazide hydrochloride; Ro 4-4602 hydrochloride |
| Therapeutic Use | Adjunct to levodopa in Parkinson’s disease |
| Ph Value | 4.5 - 6.5 (10 mg/mL in water) |
| Stability | Stable under recommended storage conditions |
As an accredited Benserazide Hydrochloride factory, we enforce strict quality protocols—every batch undergoes rigorous testing to ensure consistent efficacy and safety standards.
| Packing | Benserazide Hydrochloride is packaged in a 10g amber glass bottle with a tamper-evident cap, labeled with product details and warnings. |
| Shipping | Benserazide Hydrochloride is shipped in secure, leak-proof containers compliant with chemical safety regulations. The packaging ensures protection from moisture and light. Shipping is conducted under controlled temperatures, with appropriate labeling and documentation for safe handling and regulatory compliance. Expedited and tracked delivery options are available to ensure prompt and secure arrival. |
| Storage | Benserazide Hydrochloride should be stored at 2°C to 8°C (refrigerated) and protected from light in a tightly sealed container. It should be kept in a dry, well-ventilated area away from incompatible substances. Ensure the container is tightly closed to minimize exposure to moisture and air. Properly labeling and securing the storage area is recommended to prevent accidental exposure or contamination. |
Competitive Benserazide Hydrochloride prices that fit your budget—flexible terms and customized quotes for every order.
For samples, pricing, or more information, please contact us at +8615365186327 or mail to sales3@ascent-chem.com.
We will respond to you as soon as possible.
Tel: +8615365186327
Email: sales3@ascent-chem.com
Flexible payment, competitive price, premium service - Inquire now!
Benserazide Hydrochloride goes through a rigorous multi-step process in our facility. We focus on maintaining clean, controlled conditions for all stages, from starting materials to final powder. At each checkpoint, analytical chemists check for trace impurities because even the smallest contamination will impact the downstream application, especially in pharmaceutical settings. Over the years, our synthesis routes have evolved. We learned great lessons from earlier batches: controlling moisture content at the drying phase prevents caking, monitoring reaction times reduces by-products, and storing at the right temperature curbs degradation. These aren’t abstract process details. Every change increases reliability for research labs and pharmaceutical partners that receive our shipments.
The grade we supply meets or exceeds most leading pharmacopeial references. Our final product presents itself as a white to off-white crystalline powder. Depending on requests we take, we adjust particle size slightly for improved handling. There’s nothing casual about this work—synthesizing benserazide, isolating the hydrochloride salt, washing and drying, verifying stability, all while minimizing waste, drives our approach. Where others cut corners, we address bottleneck steps, control solvents, and invest in purification procedures. Customers notice when high-quality product arrives—flowability, consistent pack weights, and no cross-contamination from other synthesis lines.
Pharmaceutical producers primarily use Benserazide Hydrochloride as a decarboxylase inhibitor. Its most common application is pairing with levodopa for patients dealing with Parkinson’s disease. By blocking aromatic amino acid decarboxylase in the periphery, Benserazide allows more levodopa to cross into the brain, where it's converted to dopamine. This means lower peripheral dopamine, resulting in fewer side-effects such as nausea and low blood pressure for end users. It’s a critical component, not just another additive.
Over the years, we’ve fielded plenty of questions about stability, solubility, and risks during tableting. Direct compression isn’t ideal; the powder prefers to clump if exposed to high humidity or poor granulation technique. Tablets made with Benserazide Hydrochloride require consistent blending and sometimes a few trial runs in pilot batches before scaling up. On the scale-up side, the density range we maintain allows tablet producers to keep mass uniformity without fussing with excess excipient. Factory technicians report that our lots fall within narrower parameter ranges than competitors, and that consistency allows them to respond quickly to regulatory audits or customer complaints.
Speaking frankly, not all manufacturers hold the same standards. Some facilities prioritize throughput over purity. This often leads to higher residual solvent content, incomplete reactions, or product arriving with off-color or unusual odors. Our investment in upstream analytics means we limit problematic by-products, and every outgoing lot gets a certificate tied to batch-level data. Reprocessing inferior batches is costly. That's why we improve from every lesson, adapting, not recycling problems forward.
We see new entrants in the market offering 'Benserazide Hydrochloride' at lower prices. Upon inspection, these sometimes fail on heavy metals, microbial load, or even identification itself. Within our operation, we never chase numbers at the cost of patient safety. Many clients—whether coming from new suppliers or testing samples—return after a single run gone wrong. The message is clear: shortcuts put both results and patients at risk. Our focus remains on source material traceability and lot-to-lot reproducibility.
Other suppliers sometimes offer the product blended with stabilizers or additional excipients. We deliberately ship pure substance, so formulators can decide on necessary excipients themselves, allowing more control and direct integration into their manufacturing processes. For research applications, this also removes a layer of ambiguity, crucial for reproducibility in animal models or early-stage trials.
Handling Benserazide Hydrochloride looks straightforward, but anyone who’s worked in pharmaceutical production knows the devil lurks in small details. The powder tends to absorb moisture, which can complicate storage and transfer processes. We switched to low-permeability poly-lined drums after trials with standard containers led to clumping over long transit times in humid climates. Tracing customer issues back to packaging design makes it clear that experience pays off. Our switch reduced the frequency of customer-reported issues, saving time and money on both sides.
Solubility in water is another common question we field. In solution, Benserazide Hydrochloride holds up under neutral to slightly acidic conditions, but begins oxidizing if left exposed to air and light for extended periods. It’s a lesson that cost a few researchers valuable material. For the pharmaceutical plant, it pays to make up solutions fresh or, for larger batches, to keep dissolved material under nitrogen. Our technical notes ship with each order, including real-world advice collected from our own production chemists and customer input.
We also keep hearing from teams encountering problems during the blending of Benserazide with microcrystalline cellulose or other excipients. This product integrates best when added mid-blend with tight humidity control. Overdry materials can promote static cling, leading to uneven distribution. Too much moisture, on the other hand, leads to caking and throughput issues on the press. These aren't theoretical scenarios—they’re problems we've addressed with countless partners over decades.
The pharmaceutical industry faces mounting scrutiny. Global agencies and local inspectors now demand more than just a certificate of analysis. They want to review real batch records, stability documentation, and see robust supply chain control. Our production model emphasizes traceability. Every lot of Benserazide Hydrochloride gets tracked from pre-cursor arrival through synthesis, purification, and final packaging. In case regulators come calling, or a manufacturer needs batch-specific data, we offer documentation in real time. Trust builds from openness, and both researchers and production partners respond to quality they can verify.
Product recalls create headaches not just downstream, but inside our own plant. We've seen how a single low-quality shipment from a competitor ripples through the medical pipeline, risking patient health and damaging relationships. Our strategy always puts consistent, audit-friendly production ahead of racing to market. For clients submitting regulatory filings, our product history has helped clear complex audits. Those who rely on process repeatability look at our long-term batch data and make investment decisions accordingly.
Pharmaceutical standards mean more than paperwork. Particle size shapes blending behavior and tableting outcomes. Color, odor, and moisture profile identify purity and storage history. Over time, we've adjusted specification limits based on feedback. For instance, we tightened residual solvent tolerances after observing slightly tacky powders that slowed compression rates in high-speed tableting. It wasn't just about “meeting spec,” but about understanding real-world process impacts.
Some customers sought material with the lowest heavy metal profile after adjustments to finished product regulations. These requests pushed us to refine purification steps, slowing throughput yet maintaining clean product. Though some buyers argue over pricing, saving time downstream outweighs a few cents shaved per gram. The pharmaceutical engineer optimizing a process will see the value in high-grade material—less troubleshooting, fewer deviations, more reliable batch release.
Controlling moisture continues to matter in processing and storage. Benserazide Hydrochloride absorbs ambient humidity. At scale, this means unopened drums must remain sealed until use, ideally in low-humidity storage rooms. We switched bulk packaging to heavy-duty, low water vapor transmission liners years ago, after testing several alternatives. Clients storing small quantities benefit from airtight containers with desiccant, especially in climates with seasonal shifts. Feedback from the field told us that even hour-long exposures to open air can lead to subtle clumping, changing both visual qualities and handling characteristics.
Shelf-life claims reflect real experience, not just accelerated aging tests. Chemists in our team occasionally run long-term stability trials, tracking color, odor, loss on drying, and assay over the course of several years. The benchmark remains a stable powder, free-flowing and uniform in appearance. Old batches with significant yellowing or off-smell mean trouble—such stock doesn’t meet our acceptance criteria. Returned complaint frequencies matter, too. Very few requests for replacements demonstrate the value of keeping the old standards high.
We keep communication transparent with research and pharmaceutical partners. Customer input regularly shapes adjustments in process and packaging. One example stands out: feedback from a large contract manufacturer struggling with drum residue and powder loss during transfer. We responded with altered drum linings and more thoughtful filling technique, drastically reducing waste and making downstream processing more efficient. This reduces total material usage without affecting production scheduling.
Another insight involved requests from research groups for smaller-quantity packaging with the same documentation as pharmaceutical-grade drums. Previously, we focused only on bulk shipment. Now, we offer multiple sizes, all coming with full analytical profiles and compliance paperwork. This supports small batch development, academic trial use, and fast prototyping without forcing researchers to over-purchase or work with fractional lots.
Benserazide Hydrochloride rarely captures the media spotlight. Yet, its role in Parkinson’s treatment protocols changes outcomes for thousands of patients daily. Without consistent supply, neurologists and pharmacists risk shortages. Supply disruptions—caused by production line failures, regulatory shutdowns, or low-quality imports—negatively impact patients. Over our years of operation, we've learned that steady supply lines, managed with redundancy and robust logistics planning, keep lives moving forward. Our focus rests not only on synthesis, but on logistics partners, storage safety, and regulatory paperwork staying up to date.
In the research sector, Benserazide Hydrochloride provides flexibility as a biochemical tool. Projects on dopamine biosynthesis, animal models of neurodegeneration, and preclinical trials all depend on pure, reliable active intermediates. We maintain lines of communication with leading academic teams, asking about their new requirements, and occasionally co-developing custom specifications for particular experiments.
International shipment of pharmaceutical intermediates faces plenty of surprises. We handle customs delays, updating shipping documents in line with both origin and destination region demands. Temperature and moisture exposure en route drove several packaging overhauls. Early overseas shipments sometimes arrived caked or compacted. Deploying real-world transit tests, monitoring temperature swings, and adapting insulation and desiccant types improved end-user experience. We now train our logistics team in documenting chain-of-custody for major airport and shipping hub transfers.
Part of our operation looks beyond just delivering a powder—each package includes detailed batch-level paperwork, real-time updates for shipping status, and feedback surveys for continuous improvement. Clients faced with regulatory hurdles or surprise audits appreciate full transparency. Regulatory harmonization remains a future goal. Until then, we work daily with compliance teams, updating registrations and aligning technical documents whenever new requirements emerge.
Our quality system evolves with every challenge. No year goes by without adjusting at least one process step based on feedback or regulatory change. Benserazide Hydrochloride serves as a textbook example: initial efforts focused on raw yield, now we sink resources into compliance, reproducibility, and nuanced packaging improvements. Investments in new reactors and automation controls have trimmed batch variability, and regular staff training keeps technical teams alert.
Attention to process safety also contributes to reliability. Overseeing hazardous reagent storage, air quality monitoring, and engineering solid waste out of daily routines makes a visible difference during audits. Plant safety means fewer shutdowns and fewer product recalls. Our priority always remains on building and maintaining long-term client relationships, not chasing immediate gains or racing against cost-cutting competitors.
Sourcing directly from us gives customers more than product. The direct link shortens response time for troubleshooting, enables batch customization on request for research, and gives more insight into real manufacturing practices. Pharmaceutical buyers get data straight from the source. Research groups gain a trusted partner for rapid questions about handling or registration. Our goal: giving clients what they need, when they need it, with documentation that stands up to scrutiny in every region where Benserazide Hydrochloride finds use.
Staying at the forefront of manufacturing Benserazide Hydrochloride requires focus across every department. Our experience proves that sound synthesis, robust quality systems, and ongoing dialogue with customers prevent trouble before it begins. Pharmaceutical companies, researchers, and distributors all depend on this transparency, and our reputation reflects a decades-long investment in quality. As new regulations arrive, and as more competitors enter the market, we double down on our standards. Every shipment, every technical response, and every process audit reflects what we’ve learned firsthand producing, packaging, and standing behind Benserazide Hydrochloride every day.